Literature DB >> 17932350

Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.

Huan-Ming Hsu1, Hui-Chun Wang, Sou-Tong Chen, Giu-Cheng Hsu, Chen-Yang Shen, Jyh-Cherng Yu.   

Abstract

The evolutionarily conserved Mre11-Rad50-Nbs1 (MRN) complex, consisting of proteins encoded by the genes Mre11, Rad50, and Nbs1, was recently shown to play a crucial role in DNA double-strand break (DSB) repair by recruiting the nuclear protein kinase ataxia telangiectasia mutated to DSB sites, leading to activation of this DNA repair network. Given the fact that carriers of defective mutation and polymorphic variants of ataxia telangiectasia mutated are at higher risk of developing breast cancer, we hypothesized a role of the MRN genes in determining breast cancer susceptibility. This hypothesis was examined both in a case control study of 559 breast cancer patients and 1,125 healthy women of single-nucleotide polymorphisms in Mre11, Rad50, and Nbs1 and by the in vivo detection of binding between Mre11 and BRCA1, encoded by the breast cancer susceptibility gene BRCA1. We were also interested in defining whether any association between MRN genes and breast cancer was modified by reproductive risk factors reflecting the level of estrogen exposure or susceptibility to estrogen exposure, as estrogen is known to initiate breast cancer development due to its metabolites causing DSB formation. Support for the hypothesis came from the observations that (a) one single-nucleotide polymorphism in Nbs1 was significantly associated with breast cancer risk, and a trend toward an increased risk of developing breast cancer was found in women harboring a greater number of putative high-risk genotypes of MRN genes (an adjusted odds ratio of 1.25 for each additional putative high-risk genotype; 95% confidence interval, 1.10-1.44); (b) this association between risk and the number of putative high-risk genotypes was stronger and more significant in women thought to be more susceptible to estrogen, i.e., those with no history of full-term pregnancy, those older (>or=26 years of age) at first full-term pregnancy, or those having had fewer (<2) full-term pregnancies; the risk effect conferred by harboring a higher number of high-risk genotypes of MRN genes was more significant in women without a history of breast feeding; and (c) Mre11 and BRCA1 were shown to form a complex in vivo, and this interaction was increased by irradiation. This study supports the role of the MRN pathway in breast cancer development, further strengthening the suggestion that mechanisms regulating DSB repair may play a mutator role driving breast cancer pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932350     DOI: 10.1158/1055-9965.EPI-07-0116

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  42 in total

1.  Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line.

Authors:  Qi Zhao; Otavia L Caballero; Samuel Levy; Brian J Stevenson; Christian Iseli; Sandro J de Souza; Pedro A Galante; Dana Busam; Margaret A Leversha; Kalyani Chadalavada; Yu-Hui Rogers; J Craig Venter; Andrew J G Simpson; Robert L Strausberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

2.  Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk.

Authors:  Tasha R Smith; Edward A Levine; Rita I Freimanis; Steven A Akman; Glenn O Allen; Kimberly N Hoang; Wen Liu-Mares; Jennifer J Hu
Journal:  Carcinogenesis       Date:  2008-08-13       Impact factor: 4.944

3.  Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR.

Authors:  Nicola Machella; Mary Beth Terry; Jennifer Zipprich; Irina Gurvich; Yuyan Liao; Ruby T Senie; David O Kennedy; Regina M Santella
Journal:  Carcinogenesis       Date:  2008-06-19       Impact factor: 4.944

4.  Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.

Authors:  Tasha R Smith; Wen Liu-Mares; Beth O Van Emburgh; Edward A Levine; Glenn O Allen; Jeff W Hill; Isildinha M Reis; Laura A Kresty; Mark D Pegram; Mark S Miller; Jennifer J Hu
Journal:  Carcinogenesis       Date:  2011-06-23       Impact factor: 4.944

5.  Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.

Authors:  Zhenzhen Wu; Peng Wang; Chunhua Song; Kaijuan Wang; Rui Yan; Jingruo Li; Liping Dai
Journal:  Mol Genet Genomics       Date:  2015-01-09       Impact factor: 3.291

6.  The NBS1 genetic polymorphisms and the risk of the systemic lupus erythematosus in Taiwanese patients.

Authors:  Ying-Ju Lin; Yu-Ching Lan; Lei Wan; Chung-Ming Huang; Cheng-Wen Lin; Kai-Chung Hsueh; Da-Yuan Chen; Ting-Hsu Lin; Fuu-Jen Tsai
Journal:  J Clin Immunol       Date:  2010-06-23       Impact factor: 8.317

7.  The transcription factor GATA3 is required for homologous recombination repair by regulating CtIP expression.

Authors:  F Zhang; H Tang; Y Jiang; Z Mao
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

Review 8.  Understanding patient and provider perceptions and expectations of genomic medicine.

Authors:  Michael J Hall; Andrea D Forman; Susan V Montgomery; Kim L Rainey; Mary B Daly
Journal:  J Surg Oncol       Date:  2014-07-03       Impact factor: 3.454

9.  Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.

Authors:  Jirina Bartkova; Johanna Tommiska; Lenka Oplustilova; Kirsimari Aaltonen; Anitta Tamminen; Tuomas Heikkinen; Martin Mistrik; Kristiina Aittomäki; Carl Blomqvist; Päivi Heikkilä; Jiri Lukas; Heli Nevanlinna; Jiri Bartek
Journal:  Mol Oncol       Date:  2008-10-07       Impact factor: 6.603

10.  Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.

Authors:  Sylvie Desjardins; Joly Charles Beauparlant; Yvan Labrie; Geneviève Ouellette; Francine Durocher
Journal:  BMC Cancer       Date:  2009-06-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.